Debt-to-equity of RECURSION PHARMACEUTICALS, INC. from 30 Sep 2021 to 30 Sep 2025

Taxonomy & unit: ratio: %
Description: Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary: RECURSION PHARMACEUTICALS, INC. quarterly Debt-to-equity in % history and change rate from 30 Sep 2021 to 30 Sep 2025.
RECURSION PHARMACEUTICALS, INC. Debt-to-equity for the quarter ending 30 Sep 2025 was 39%, a 3% increase year-over-year.

Debt-to-equity, Quarterly (%)

Debt-to-equity, YoY Quarterly Change (%)

RECURSION PHARMACEUTICALS, INC. Quarterly Debt-to-equity (%)

Period	Value	YoY Chg	Change %	Date
Q3 2025	39%	+1%	+3%	30 Sep 2025
Q2 2025	40%	+1%	+3.6%	30 Jun 2025
Q1 2025	38%	-3%	-8%	31 Mar 2025
Q4 2024	38%	-5%	-12%	31 Dec 2024
Q3 2024	38%	-7%	-15%	30 Sep 2024
Q2 2024	39%	-8%	-18%	30 Jun 2024
Q1 2024	42%	-8%	-17%	31 Mar 2024
Q4 2023	43%	-7%	-15%	31 Dec 2023
Q3 2023	44%	+3%	+7%	30 Sep 2023
Q2 2023	47%	+18%	+62%	30 Jun 2023
Q1 2023	50%	+31%	+169%	31 Mar 2023
Q4 2022	51%	+35%	+228%	31 Dec 2022
Q3 2022	41%	+13%	+44%	30 Sep 2022
Q2 2022	29%			30 Jun 2022
Q1 2022	19%			31 Mar 2022
Q4 2021	15%			31 Dec 2021
Q3 2021	29%			30 Sep 2021

* An asterisk sign (*) next to the value indicates that the value is likely invalid.